1. International Headache Society Classification Committee. The International Classification of Headache disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.
2.
Freilich JE, Kuter-Shorrer M, Treister NS, et al. Burning mouth syndrome: a diagnostic challeng. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 129: 120–124.
3.
Tan HL, Renton T. Burning mouth syndrome: an update. Cephalalgia Reports 2020; 3, doi: 10.1177/2515816320970143.
4.
Minor JS, Epstein JB. Burning mouth syndrome and secondary oral burning. Otolaryngol Clin North Am 2011; 44(1): 205–219.
5.
Varoni EM, Lo Faro AF, Lodi G, et al. Melatonin Treatment in Patients with Burning Mouth Syndrome: A Triple-Blind, Placebo-Controlled, Crossover Randomized Clinical Trial. J Oral Facial Pain Headache 2018; 32(2): 178–188.
6.
McMillan R, Forssell H, Buchanan JA, et al. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev 2016; 11(11): CD002779.
7.
Moghadam-Kia S, Fazel N. A diagnostic and therapeutic approach to primary burning mouth syndrome. Clin Dermatol 2017; 35(5): 453–460.
8.
Valenzuela S, Lopez‐Jornet P. Effects of low‐level laser therapy on burning mouth syndrome. J Oral Rehabil 2017; 44: 125–132.
9.
Sikora M, Včev A, Siber S, et al. The Efficacy of Low-Level Laser Therapy in Burning Mouth Syndrome – A Pilot Study. Acta Clin Croat 2018; 57(2): 312–315.
10.
Bardellini E, Amadori F, Conti G, et al. Efficacy of the photobiomodulation therapy in the treatment of the burning mouth syndrome. Med Oral Patol Oral Cir Bucal 2019; 24(6): e787–e791.
11.
Ottaviani G, Rupel K, Gobbo M, et al. Efficacy of ultramicronized palmitoylethanolamide in burning mouth syndrome-affected patients: a preliminary randomized double-blind controlled trial. Clin Oral Investig 2019; 23(6): 2743–2750.
12.
Treldal C, Jacobsen CB, Mogensen S, et al. Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome. Oral Dis 2016; 22(2): 123–131.
13.
Valenzuela S, Pons-Fuster A, López-Jornet P. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial. J Oral Pathol Med 2016; 45(7): 528–533.
14.
Zoric B, Jankovic L, Kuzmanovic Pficer J, et al. The efficacy of fluoxetine in BMS-A cross-over study. Gerodontology 2018; 35(2): 123–128.
15.
Maina G, Vitalucci A, Gandolfo S, et al. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002; 63(1): 38–43.
16.
Carbone M, Pentenero M, Carrozzo M, et al. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009; 13(5): 492–496.
17.
Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome – a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009; 38(3): 254–261.
18.
López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009; 36(1): 52–57.
19.
Cano-Carrillo P, Pons-Fuster A, López-Jornet P. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised. J Oral Rehabil 2014; 41(4): 296–305.
20.
Sardella A, Lodi G, Demarosi F, et al. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med 2008; 37(7): 395–401.
21.
Alvarenga da Silva L, Siqueira JT, Teixeira MJ, et al. The role of xerostomia in burning mouth syndrome: a casecontrol study. Arquivos de Neuro-psiquiatria 2014; 72(2): 91–98.
22.
Femiano F, Gombos F, Scully C, et al. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000; 6(5): 274–277.
23.
Marino R, Torretta S, Capaccio P, et al. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med 2010; 39(8): 611–616.
24.
Spanemberg JC, López López J, de Figueiredo MA, et al. Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial. J Biomed Opt 2015; 20(9): 098001.
